-
Sector Analysis
![]()
Spirometers Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Spirometers Market Report Overview The spirometer market size was valued at $109.2 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. A Spirometer is used to measure the amount of air inhaled or exhaled by a patient and the rate at which the air is moved into or out of the lungs in a lung function test. It has applications in the diagnosis and monitoring of diseases such as asthma, and...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – Roxadustat in Chemotherapy Induced Anemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Roxadustat in Chemotherapy Induced Anemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Roxadustat in Chemotherapy Induced Anemia Drug Details: Roxadustat (Ai Ruizhuo, Evrenzo)...
-
Product Insights
![]()
Switzerland Spirometers Market Share
Spirometers (Anesthesia and Respiratory Devices) Switzerland Market Share report provides quantitative market trends within the Anesthesia and Respiratory Devices therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
![]()
United States Spirometers Market Share
Spirometers (Anesthesia and Respiratory Devices) United States Market Share report provides quantitative market trends within the Anesthesia and Respiratory Devices therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Company Profile
![]()
e-Therapeutics Plc – Company Profile
e-Therapeutics Plc (e-Therapeutics) is a drug discovery and development company with a focus on discovering novel therapeutic approaches and mechanisms for the treatment of various diseases such as cancer, diabetes, and neurodegenerative disease. It carries out its work by integrating proprietary databases and computational tools that use network analysis, machine learning, Al, data mining, and optimization. The company harnesses its two proprietary, productive, and unique technology platforms, Network-Driven Drug Discovery (NDD) and Genome Associated Network Interactions (GAINs), for the target...
Add to Basket -
Product Insights
![]()
ndd Medizintechnik AG, United States Revenue
GlobalData, the industry analysis specialist, has released its latest report: ndd Medizintechnik AG, United States Revenue. The medical devices sector is typified by frequent change and innovation in available devices, in response to demand from healthcare for ever more effective therapies and increased competition. As a result, the sector has seen the emergence of start-up medtech companies who are producing the most innovative and cutting-edge solutions to problems and issues faced by the healthcare industry. Most of these companies are...
-
Company Profile
![]()
Wockhardt Ltd – Company Profile
Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, formulations and biosimilars. Its product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes. The company also concentrates its research in new chemical entities (NCE), generics, abbreviated new drug applications (ANDAs), biosimilars, novel drug delivery systems (NDDS). It operates in India, the US, the UK and the emerging markets. Wockhardt is headquartered in...
Add to Basket -
Company Profile
![]()
Shilpa Medicare Ltd – Company Profile
Shilpa Medicare Ltd (Shilpa Medicare) focuses on the development, manufacture, and commercialization of generic pharmaceutical products and active pharmaceutical ingredients (APIs) and formulations for both domestic and international markets. The company product portfolio is spread across non-oncology and oncology therapeutic areas. The formulations are provided in a full range of injectable and oral dosage forms. The company also offers contract research and manufacturing services for APIs, formulations, new drug delivery systems (NDDS), specialty chemicals, and biotech products. It exports its...
Add to Basket -
Company Profile
![]()
FibroGen Inc – Company Profile
FibroGen Inc (FibroGen) is a biopharmaceutical company that discovers, and develops medicines for the treatment of anemia, cancer, and fibrotic disease. Its approved product includes roxadustat for the treatment of treatment of anemia associated with chronic kidney disease, in both dialysis-dependent (DD) and non-dialysis-dependent (NDD) patients. Its pipeline product includes pamrevlumab (FG-3019) for the treatment of idiopathic pulmonary fibrosis (IPF) and duchenne muscular dystrophy (DMD). The company has operations in the US, Hong Kong, Finland, Cayman Islands and China. FibroGen...
Add to Basket -
Product Insights
![]()
Net Present Value Model: Venofer
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Venofer Drug Details Iron sucrose (Venofer,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.